Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $102

Benzinga Newsdesk www.benzinga.com Negative 94.0%

Neg 94% Neu 0% Pos 0%

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $112 to $102.